Extended release oral milrinone as an adjunct to heart failure therapy

Intern Med J. 2017 Aug;47(8):973-974. doi: 10.1111/imj.13503.

Authors

Shane Nanayakkara^{1

2

3}, Peter Bergin¹, Vivian Mak¹, Karina Crannitch¹, David M Kaye^{1

2

3}

Affiliations

¹ Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
² Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
³ Department of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.

PMID: 28782207
DOI: 10.1111/imj.13503

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Adult
Cardiotonic Agents / administration & dosage*
Delayed-Action Preparations / administration & dosage
Drug Therapy, Combination
Heart Failure / diagnostic imaging*
Heart Failure / drug therapy*
Humans
Male
Milrinone / administration & dosage*

Substances

Cardiotonic Agents
Delayed-Action Preparations
Milrinone